GeneOne Life Science, Inc. (KRX:011000)
2,120.00
+20.00 (0.95%)
At close: Nov 5, 2025
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 180.2 billion as of November 5, 2025. Its market cap has decreased by -5.75% in one year.
Market Cap
180.20B
Enterprise Value
203.36B
Revenue
34.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,120.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 180.20B, an increase of 5,199.97%. That is a compound annual growth rate of 14.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 178.92B | 5.97% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | 961.06B | 1,733.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 56.52T |
| Celltrion | 38.68T |
| ALTEOGEN | 26.13T |
| SK Biopharmaceuticals | 9.05T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.31T |
| PharmaResearch | 5.62T |